- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x GOL: GLYCEROL(Non-functional Binders)
- 22 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 8 residues within 4Å:- Chain A: D.71, M.72, D.73, T.268, N.269, S.270, K.311
- Ligands: MG.10
Ligand excluded by PLIPSO4.4: 5 residues within 4Å:- Chain A: G.149, P.150, R.153, K.159
- Chain B: K.363
Ligand excluded by PLIPSO4.5: 7 residues within 4Å:- Chain A: T.116, E.393, Q.396, E.397, Y.453, G.457, L.459
Ligand excluded by PLIPSO4.6: 6 residues within 4Å:- Chain A: V.320, L.321, T.335, T.337
- Chain C: F.210, S.212
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: D.271, D.308, G.329, L.331
Ligand excluded by PLIPSO4.8: 6 residues within 4Å:- Chain A: T.166, E.167, Y.170, R.214, F.217, Q.218
Ligand excluded by PLIPSO4.9: 5 residues within 4Å:- Chain A: L.502, E.506, S.507, V.509
- Chain B: W.401
Ligand excluded by PLIPSO4.15: 8 residues within 4Å:- Chain B: D.71, M.72, D.73, T.268, N.269, S.270, K.311
- Ligands: MG.19
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain A: K.363
- Chain B: G.149, P.150, R.153, K.159
Ligand excluded by PLIPSO4.17: 5 residues within 4Å:- Chain B: F.176, R.221, V.224, D.225, H.228
Ligand excluded by PLIPSO4.18: 4 residues within 4Å:- Chain B: L.502, E.506, S.507, V.509
Ligand excluded by PLIPSO4.24: 8 residues within 4Å:- Chain C: D.71, M.72, D.73, T.268, N.269, S.270, K.311
- Ligands: MG.31
Ligand excluded by PLIPSO4.25: 5 residues within 4Å:- Chain C: G.149, P.150, R.153, K.159
- Chain D: K.363
Ligand excluded by PLIPSO4.26: 7 residues within 4Å:- Chain C: T.116, E.393, Q.396, E.397, Y.453, G.457, L.459
Ligand excluded by PLIPSO4.27: 6 residues within 4Å:- Chain A: F.210, S.212
- Chain C: V.320, L.321, T.335, T.337
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain C: D.271, D.308, G.329, L.331
Ligand excluded by PLIPSO4.29: 6 residues within 4Å:- Chain C: T.166, E.167, Y.170, R.214, F.217, Q.218
Ligand excluded by PLIPSO4.30: 5 residues within 4Å:- Chain C: L.502, E.506, S.507, V.509
- Chain D: W.401
Ligand excluded by PLIPSO4.36: 8 residues within 4Å:- Chain D: D.71, M.72, D.73, T.268, N.269, S.270, K.311
- Ligands: MG.40
Ligand excluded by PLIPSO4.37: 5 residues within 4Å:- Chain C: K.363
- Chain D: G.149, P.150, R.153, K.159
Ligand excluded by PLIPSO4.38: 5 residues within 4Å:- Chain D: F.176, R.221, V.224, D.225, H.228
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain D: L.502, E.506, S.507, V.509
Ligand excluded by PLIP- 8 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
MG.10: 4 residues within 4Å:- Chain A: D.71, D.73, D.370
- Ligands: SO4.3
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:D.71, A:D.71, A:D.73, A:D.370
MG.11: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)MG.19: 4 residues within 4Å:- Chain B: D.71, D.73, D.370
- Ligands: SO4.15
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.71, B:D.71, B:D.73, B:D.370, H2O.2
MG.20: 4 residues within 4Å:- Chain B: R.58, T.387, Y.476, D.478
No protein-ligand interaction detected (PLIP)MG.31: 4 residues within 4Å:- Chain C: D.71, D.73, D.370
- Ligands: SO4.24
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:D.71, C:D.71, C:D.73, C:D.370
MG.32: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)MG.40: 4 residues within 4Å:- Chain D: D.71, D.73, D.370
- Ligands: SO4.36
5 PLIP interactions:4 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.71, D:D.71, D:D.73, D:D.370, H2O.5
MG.41: 4 residues within 4Å:- Chain D: R.58, T.387, Y.476, D.478
No protein-ligand interaction detected (PLIP)- 4 x 53O: 1-(biphenyl-3-yl)-1H-imidazole(Non-covalent)
53O.12: 6 residues within 4Å:- Chain A: S.59, L.495, R.497
- Chain B: Q.439, S.464, R.465
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:R.465
53O.21: 6 residues within 4Å:- Chain A: Q.439, S.464, R.465
- Chain B: R.58, S.59, R.497
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:R.58, A:R.465
53O.33: 6 residues within 4Å:- Chain C: S.59, L.495, R.497
- Chain D: Q.439, S.464, R.465
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:R.465
53O.42: 6 residues within 4Å:- Chain C: Q.439, S.464, R.465
- Chain D: R.58, S.59, R.497
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:R.465, D:R.58
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Marton, Z. et al., Identification of Noncompetitive Inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach. J.Med.Chem. (2015)
- Release Date
- 2015-12-23
- Peptides
- Cytosolic purine 5'-nucleotidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x GOL: GLYCEROL(Non-functional Binders)
- 22 x SO4: SULFATE ION(Non-functional Binders)
- 8 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
- 4 x 53O: 1-(biphenyl-3-yl)-1H-imidazole(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Marton, Z. et al., Identification of Noncompetitive Inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach. J.Med.Chem. (2015)
- Release Date
- 2015-12-23
- Peptides
- Cytosolic purine 5'-nucleotidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B